Pharmacology of levonorgestrel and ethinyl estradiol
Pro Research Analysisby 
Searched over 200M research papers
Pharmacokinetics of Levonorgestrel and Ethinyl Estradiol
Levonorgestrel (LNG) and ethinyl estradiol (EE) are commonly used together in combined oral contraceptives. Their pharmacokinetics have been studied extensively, showing moderate variability in maximum concentration (Cmax) and area under the curve (AUC) across different products and populations, with consistent drug exposure indices across studies and countries . When administered as a low-dose oral contraceptive, both drugs reach steady-state concentrations within a few weeks, and their systemic exposure remains stable with extended regimens, such as 12-week continuous use, without further accumulation .
Bioavailability and Formulation Differences
The bioavailability of LNG is similar whether administered as a tablet or a solution, but EE shows lower bioavailability in tablet form compared to solution, possibly due to decreased absorption or increased presystemic elimination . Transdermal delivery systems for LNG/EE provide daily hormone exposure comparable to low-dose oral contraceptives, with similar safety and tolerability profiles .
Impact of Obesity and Drug Interactions
Obesity significantly alters the pharmacokinetic parameters of LNG and EE, including clearance, half-life, and time to steady state, but these changes do not necessarily correlate with reduced contraceptive effectiveness . Drug-drug interactions are a concern, especially with medications that induce or inhibit CYP3A4, the enzyme responsible for LNG metabolism. CYP3A4 inducers can reduce LNG exposure, while inhibitors can increase it, but the relative impact is similar in both normal and obese women . Some drugs, like levetiracetam and zibotentan, do not significantly affect the pharmacokinetics or efficacy of LNG/EE contraceptives, supporting their safe co-administration 56.
Mechanisms of Action and Hormonal Effects
LNG acts as a progestin, while EE is a synthetic estrogen. Together, they prevent ovulation, thicken cervical mucus, and alter the endometrial lining to prevent pregnancy . EE can inhibit hepatic metabolism and induce sex hormone-binding globulin, affecting the pharmacokinetics of both hormones 18.
Central Nervous System and Behavioral Effects
Animal studies suggest that LNG and EE can influence cognition and anxiety, possibly by altering neurotransmitter and neurotrophic factor expression in the brain. Low doses may decrease anxiety and impair memory, while higher doses can have the opposite effect .
Conclusion
Levonorgestrel and ethinyl estradiol, whether delivered orally or transdermally, have well-characterized pharmacokinetics with moderate variability and predictable systemic exposure. Their effectiveness can be influenced by obesity and certain drug interactions, but most commonly used medications do not significantly compromise their contraceptive efficacy. Both hormones work together to reliably prevent pregnancy, with additional effects on hormone binding and, potentially, the central nervous system.
Sources and full results
Most relevant research papers on this topic